D. E. SHAW & CO, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT)

Filing Manager: D. E. SHAW & CO, L.P.
Reporting Manager: D. E. Shaw & Co., L.P.
Security: Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: SRPT
Shares outstanding: 105,632,895 shares
Disclosed Ownership: 2,007,025 shares
Ownership: 1.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:08:26 UTC
Date of event: 30 Sep 2025
Previous filing: 25 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
D. E. Shaw & Co., L.P.	1.9%	2,007,025	0	1,984,525	/s/ Daniel R. Marcus	Daniel R. Marcus / Chief Compliance Officer
David E. Shaw	1.9%	2,007,025	0	1,984,525	/s/ Daniel R. Marcus	Daniel R. Marcus / Attorney-in-Fact for David E. Shaw